Volume : 13, Issue : 01, January – 2026

Title:

FORMULATION AND CHARACTERIZATION OF INVASOMAL GEL OF KETOPROFEN FOR EFFECTIVE TREATMENT OF TOPICAL INFLAMMATION

Authors :

Prashant Mishra*, Stakar Prasad

Abstract :

The present study aimed to formulate and characterize a Ketoprofen-loaded invasomal gel for effective topical treatment of inflammation. Invasomes were prepared using phospholipids, ethanol, and penetration enhancers to overcome the barrier properties of the stratum corneum and enhance skin permeation. The prepared invasomal formulations (IN1–IN6) were evaluated for entrapment efficiency and vesicle size, and the optimized formulation IN2 exhibited the highest entrapment efficiency (82.25 ± 0.36%) with a minimum vesicle size (204.36 nm). The optimized invasomes were incorporated into a gel base to improve patient compliance and prolong residence time at the site of application. The invasomal gel formulations (IG-1 to IG-3) were evaluated for viscosity, pH, drug content, extrudability, and spreadability, and formulation IG-2 showed optimal physicochemical properties with maximum drug content (99.12 ± 0.54%) and skin-compatible pH. In vitro drug release studies demonstrated a sustained release of Ketoprofen up to 12 hours from the invasomal gel compared to rapid release from the pure drug. Release kinetics revealed that the formulation followed the Korsmeyer–Peppas model, indicating a diffusion-controlled release mechanism. Stability studies confirmed that the optimized invasomal gel remained stable for up to 6 months, particularly under refrigerated conditions.
The study concludes that the Ketoprofen invasomal gel is a promising topical drug delivery system capable of enhancing skin penetration, providing sustained drug release, and improving therapeutic efficacy in the management of topical inflammation.
Keywords: Ketoprofen, Invasomes, Topical drug delivery, Invasomal gel, Entrapment efficiency, Sustained release, Skin permeation.

Cite This Article:

Please cite this article in press Prashant Mishra et al., Formulation And Characterization Of Invasomal Gel Of Ketoprofen For Effective Treatment Of Topical Inflammation, Indo Am. J. P. Sci, 2026; 13(01).

REFERENCES:

1. Placha D, Jampilek J. Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems. Pharmaceutics. 2021 Jan 6;13(1):64.
2. Barkin RL. Topical nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and therapeutic outcome. American journal of therapeutics. 2015 Sep 1;22(5):388-407.
3. Chawla G, Ranjan C, Kumar J, A Siddiqui A. Chemical modifications of ketoprofen (NSAID) in search of better lead compounds: A Review of literature from 2004-2016. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents). 2016 Dec 1;15(3):154-77.
4. Kumar B, Sahani V, Patil S. Review on Ketoprofen (Anti-Inflammatory Drug). J. Res. Appl. Sci. Biotechnol. 2024;3:41-50.
5. Prausnitz MR, Elias PM, Franz TJ, Schmuth M, Tsai JC, Menon GK, Holleran WM, Feingold KR. Skin barrier and transdermal drug delivery. Dermatology. 2012 Jan;3(18):2065-73.
6. Trommer H, Neubert RH. Overcoming the stratum corneum: the modulation of skin penetration: a review. Skin pharmacology and physiology. 2006 May 12;19(2):106-21.
7. Kumar B, Pandey M, Aggarwal R, Sahoo PK. A comprehensive review on invasomal carriers incorporating natural terpenes for augmented transdermal delivery. Future Journal of Pharmaceutical Sciences. 2022 Dec 2;8(1):50.
8. Jain S, Tripathi S, Tripathi PK. Invasomes: Potential vesicular systems for transdermal delivery of drug molecules. Journal of Drug Delivery Science and Technology. 2021 Feb 1;61:102166.
9. Cunha IV, Campos AM, Gerola AP, Caon T. Effect of invasome composition on membrane fluidity, vesicle stability and skin interactions. International Journal of Pharmaceutics. 2023 Nov 5;646:123472.
10. Tonge MR, Pimpalshende PM, Kosalge SB. Advancements in invasomes for enhanced drug delivery: A comprehensive review. AJPER. 2024;13(1):15-26.
11. Strazzabosco G, Liboni A, Pezzi G, Alogna A, Bortolotti D. Insights into Liposomal and Gel-Based Formulations for Dermatological Treatments. Gels. 2025 Mar 26;11(4):245.
12. Dragicevic-Curic, N., Gräfe, S., Albrecht, V., and Fahr, A., (2008), “Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study,”JPhotochem. Photobiol. B., 91(1), pp. 41-50.
13. Aggarwal, D., and Kaur, IP., (2005), “Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system,” Int J Pharm., 290(1- 2), pp. 155-159.
14. Ayman F. El-Kattan, Charles S. Asbill, Nanhye Kim, Bozena B. Michniak. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. International Journal of Pharmaceutics. 2001; 215: 229-240.
15. Amnuaikit, T., Limsuwan, T., Khongkow, P., and Boonme, P., (2018), “Vesicular carriers containing phenylethyl resorcinol for topical delivery system; liposomes, transfersomes and invasomes,” Asian J Pharm. Sci., 13(5), pp. 472-84.
16. Manchanda, S., and Sahoo, PK., (2018), “Fabrication and characterization of mucoadhesive topical nanoformulations of dorzolamide HCl for ocular hypertension,” J. Pharm. Investig., 48, pp. 323–332.
17. Singh P, Jain G, Namdev P, Singhai A. Formulation and Evaluation of Luliconazole Loaded Invasomes. Asian Journal of Pharmaceutical Education and Research. 2020; 10 (4): 79-88.
18. Kumar, B., Sahoo, P., and Manchanda, S., (2022), “Development of eucalyptol enriched nano vesicles for better transdermal delivery of curcumin: Preparation, characterisation and ex vivo skin analysis,” Nanomed J., 9(3), pp. 223-230.
19. Chandra, A., Aggarwal, G., Manchanda, S., and Narula, A., (2019), “Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis,” Pharm Nanotechnol., 7(5), pp. 362-374.
20. Bachhav, Y. G., and Patravale, V. B., (2009), “Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation, and stability studies,” AAPS PharmSciTech., 10(2), pp. 476–481.
21. Sareen, R., Kumar, S., and Gupta, G. D., (2011), “Meloxicam carbopol-based gels: characterization and evaluation,” Curr Drug Deliv, 8(4), pp. 407–415.